125 related articles for article (PubMed ID: 27658346)
1. Pharmacological characterization of a series of aryl-sulfonamide derivatives that potently and selectively inhibit monoacylglycerol acyltransferase 2.
Adachi R; Ishii T; Ogawa K; Matsumoto S; Satou T; Sakamoto J; Sato K; Kawamoto T
Eur J Pharmacol; 2016 Nov; 791():569-577. PubMed ID: 27658346
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Human Intestinal MGAT Inhibitors Using High-Throughput Mass Spectrometry.
Adachi R; Ishii T; Matsumoto S; Satou T; Sakamoto J; Kawamoto T
SLAS Discov; 2017 Apr; 22(4):360-365. PubMed ID: 28328319
[TBL] [Abstract][Full Text] [Related]
3. Novel LC/MS/MS and High-Throughput Mass Spectrometric Assays for Monoacylglycerol Acyltransferase Inhibitors.
Qi J; Masucci JA; Lang W; Connelly MA; Caldwell GW; Petrounia I; Kirkpatrick J; Barnakov AN; Struble G; Miller R; Dzordzorine K; Kuo GH; Gaul M; Pocai A; Lee S
SLAS Discov; 2017 Apr; 22(4):433-439. PubMed ID: 28328322
[TBL] [Abstract][Full Text] [Related]
4. Characterization of monoacylglycerol acyltransferase 2 inhibitors by a novel probe in binding assays.
Ma Z; Chao HJ; Turdi H; Hangeland JJ; Friends T; Kopcho LM; Lawrence RM; Cheng D
Anal Biochem; 2016 May; 501():48-55. PubMed ID: 26925857
[TBL] [Abstract][Full Text] [Related]
5. Properties of the mouse intestinal acyl-CoA:monoacylglycerol acyltransferase, MGAT2.
Cao J; Burn P; Shi Y
J Biol Chem; 2003 Jul; 278(28):25657-63. PubMed ID: 12730219
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a Novel Series of N-Phenylindoline-5-sulfonamide Derivatives as Potent, Selective, and Orally Bioavailable Acyl CoA:Monoacylglycerol Acyltransferase-2 Inhibitors.
Sato K; Takahagi H; Yoshikawa T; Morimoto S; Takai T; Hidaka K; Kamaura M; Kubo O; Adachi R; Ishii T; Maki T; Mochida T; Takekawa S; Nakakariya M; Amano N; Kitazaki T
J Med Chem; 2015 May; 58(9):3892-909. PubMed ID: 25897973
[TBL] [Abstract][Full Text] [Related]
7. Cloning and functional characterization of a mouse intestinal acyl-CoA:monoacylglycerol acyltransferase, MGAT2.
Cao J; Lockwood J; Burn P; Shi Y
J Biol Chem; 2003 Apr; 278(16):13860-6. PubMed ID: 12576479
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological Inhibition of Monoacylglycerol O-Acyltransferase 2 Improves Hyperlipidemia, Obesity, and Diabetes by Change in Intestinal Fat Utilization.
Take K; Mochida T; Maki T; Satomi Y; Hirayama M; Nakakariya M; Amano N; Adachi R; Sato K; Kitazaki T; Takekawa S
PLoS One; 2016; 11(3):e0150976. PubMed ID: 26938273
[TBL] [Abstract][Full Text] [Related]
9. Optimization of a novel series of N-phenylindoline-5-sulfonamide-based acyl CoA:monoacylglycerol acyltransferase-2 inhibitors: Mitigation of CYP3A4 time-dependent inhibition and phototoxic liabilities.
Sato K; Takahagi H; Kubo O; Hidaka K; Yoshikawa T; Kamaura M; Nakakariya M; Amano N; Adachi R; Maki T; Take K; Takekawa S; Kitazaki T; Maekawa T
Bioorg Med Chem; 2015 Aug; 23(15):4544-4560. PubMed ID: 26100443
[TBL] [Abstract][Full Text] [Related]
10. Membrane topology of human monoacylglycerol acyltransferase-2 and identification of regions important for its localization to the endoplasmic reticulum.
McFie PJ; Izzard S; Vu H; Jin Y; Beauchamp E; Berthiaume LG; Stone SJ
Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):1192-1204. PubMed ID: 27373844
[TBL] [Abstract][Full Text] [Related]
11. MGAT2, a monoacylglycerol acyltransferase expressed in the small intestine.
Yen CL; Farese RV
J Biol Chem; 2003 May; 278(20):18532-7. PubMed ID: 12621063
[TBL] [Abstract][Full Text] [Related]
12. Diacylglycerol acyltransferase-2 (DGAT2) and monoacylglycerol acyltransferase-2 (MGAT2) interact to promote triacylglycerol synthesis.
Jin Y; McFie PJ; Banman SL; Brandt C; Stone SJ
J Biol Chem; 2014 Oct; 289(41):28237-48. PubMed ID: 25164810
[TBL] [Abstract][Full Text] [Related]
13. Metabolic tracing of monoacylglycerol acyltransferase-2 activity in vitro and in vivo.
Qi J; Lang W; Connelly MA; Du F; Liang Y; Caldwell GW; Martin T; Hansen MK; Kuo GH; Gaul MD; Pocai A; Lee S
Anal Biochem; 2017 May; 524():68-75. PubMed ID: 27665677
[TBL] [Abstract][Full Text] [Related]
14. A predominant role of acyl-CoA:monoacylglycerol acyltransferase-2 in dietary fat absorption implicated by tissue distribution, subcellular localization, and up-regulation by high fat diet.
Cao J; Hawkins E; Brozinick J; Liu X; Zhang H; Burn P; Shi Y
J Biol Chem; 2004 Apr; 279(18):18878-86. PubMed ID: 14966132
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Selective Small Molecule Inhibitors of Monoacylglycerol Acyltransferase 3.
Huard K; Londregan AT; Tesz G; Bahnck KB; Magee TV; Hepworth D; Polivkova J; Coffey SB; Pabst BA; Gosset JR; Nigam A; Kou K; Sun H; Lee K; Herr M; Boehm M; Carpino PA; Goodwin B; Perreault C; Li Q; Jorgensen CC; Tkalcevic GT; Subashi TA; Ahn K
J Med Chem; 2015 Sep; 58(18):7164-72. PubMed ID: 26258602
[TBL] [Abstract][Full Text] [Related]
16. The monoacylglycerol acyltransferase pathway contributes to triacylglycerol synthesis in HepG2 cells.
McFie PJ; Patel A; Stone SJ
Sci Rep; 2022 Mar; 12(1):4943. PubMed ID: 35322811
[TBL] [Abstract][Full Text] [Related]
17. Human intestinal monoacylglycerol acyltransferase: differential features in tissue expression and activity.
Lockwood JF; Cao J; Burn P; Shi Y
Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E927-37. PubMed ID: 12824082
[TBL] [Abstract][Full Text] [Related]
18. Identification of 2-[2-(4-tert-butylphenyl)ethyl]-N-(4-fluorophenyl)-1,2,3,4-tetrahydroisoquinoline-6-sulfonamide (29) as an orally available MGAT2 inhibitor.
Busujima T; Tanaka H; Shirasaki Y; Munetomo E; Saito M; Kitano K; Minagawa T; Yoshida K; Osaki N; Sato N
Bioorg Med Chem; 2015 Sep; 23(17):5922-31. PubMed ID: 26210160
[TBL] [Abstract][Full Text] [Related]
19. Identification and design of a novel series of MGAT2 inhibitors.
Barlind JG; Buckett LK; Crosby SG; Davidsson Ö; Emtenäs H; Ertan A; Jurva U; Lemurell M; Gutierrez PM; Nilsson K; O'Mahony G; Petersson AU; Redzic A; Wågberg F; Yuan ZQ
Bioorg Med Chem Lett; 2013 May; 23(9):2721-6. PubMed ID: 23541669
[TBL] [Abstract][Full Text] [Related]
20. Cell-based assay of MGAT2-driven diacylglycerol synthesis for profiling inhibitors: use of a stable isotope-labeled substrate and high-resolution LC/MS.
Onorato JM; Chu CH; Ma Z; Kopcho LM; Chao HJ; Lawrence RM; Cheng D
J Lipid Res; 2015 Mar; 56(3):747-753. PubMed ID: 25598079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
